Press release
Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroids with Uterine Fibroid Embolization
Bharath Hospital Kottayam is excited introduce the latest advancement in women's healthcare - the Uterine Fibroid Embolization (UFE) treatment. Uterine fibroids are non-cancerous growths that form in the uterus. They are a common condition among women, especially those of reproductive age. These tumors can vary in size, from small growths to large masses that can distort the shape of the uterus. Although many women with uterine fibroids experience no symptoms, some women may suffer from heavy menstrual bleeding, pelvic pain or pressure, frequent urination, constipation, and back pain. Fibroids can also cause fertility problems and complications during pregnancy.Uterine fibroid embolization is a minimally invasive procedure that blocks the blood supply to the fibroids, causing them to shrink. The procedure is performed by Interventional radiologist who inserts a thin, flexible catheter into an artery in the groin and guides it to the blood vessels that supply the fibroids. Small particles are then injected into the vessels, blocking the blood flow to the fibroids. Without a blood supply, the fibroids shrink and eventually die. The procedure usually takes less than an hour, and most women can go home the same day. Recovery time is typically about a week, and most women can return to normal activities within two weeks.
Bharath Hospital's highly skilled team of Interventional radiologists have the experience and expertise in performing this innovative procedure safely & effectively and we have done this procedure successfully. With state-of-the-art equipment and facilities, patients can trust that they are receiving the best care possible at Bharath Hospital Kottayam. Beyond their expertise in UFE, Bharath Hospital is committed to providing personalized care and support to their patients throughout their treatment and recovery.
UFE is a safe and effective treatment for uterine fibroids that can help women avoid surgery and its associated risks. If you or a loved one is experiencing symptoms of uterine fibroids, Bharath Hospital in Kottayam is the place to turn for the latest in women's health innovations. Contact Bharath Hospital today to learn more about UFE and how it can help you.
To know more about us, visit: https://www.bharathhospital.co.in/
Bharath Hospital,
Azad Lane, Kottayam, Kerala, India - 686 001
Email: marketing@bharathhospital.co.in
Phone: +91 9744711000
At Bharath Hospitals, we are proud to be a leading healthcare provider in Kerala, India. With a legacy dating back to 1969, we have grown to become a multidisciplinary super-specialty hospital with 25+ departments.We have always put our patients first, and our team of experienced medical professionals is dedicated to delivering personalized and compassionate care. We use the latest medical advancements to provide a range of services, including diagnostics, surgeries, and critical care. Our goal is to promote wellness, prevent illness, provide timely and effective treatment to those in need and we are dedicated to making healthcare accessible and affordable to all.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroids with Uterine Fibroid Embolization here
News-ID: 3036620 • Views: …
More Releases from Bharath Hospital Kottayam

Bharath Hospital Kottayam: Bringing Cutting-Edge Liver Cancer Treatment to centr …
Bharath Hospital is revolutionizing liver cancer treatment in central Kerala with advanced technology. Liver cancer is a significant health concern globally and specifically in India, with many patients arriving at the hospital at an advanced stage where surgery is no longer an option. Traditional treatment methods such as chemotherapy and radiotherapy are also not always effective. However, a new therapeutic option, called TARE (Trans-arterial Radio Embolization), is now available at…
More Releases for UFE
Australia Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Australia Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "Australia Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Australia Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and…
Japan Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Japan Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "Japan Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Japan Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and…
Canada Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Canada Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "Canada Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Canada Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and…
India Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title India Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "India Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the India Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and…
United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the United States Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve…
Russia Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Russia Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "Russia Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Russia Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and…